Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...
A research team at Duke University has developed a new AI framework that can uncover simple, understandable rules that govern ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback